English
简体中文
Total: £ 56.28
Published Date: 2026-02-09 | Pages: 116 | Tables: 112 | Pharma & Healthcare
The global Qingkailing Injection market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Qingkailing Injection competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Qingkailing injection is a compound preparation of traditional Chinese medicine; it has the effects of clearing away heat and detoxifying, resolving phlegm and unblocking meridians, refreshing the mind and invigorating the orifices; it is used for fever, coma, hemiplegia caused by stroke, and mental confusion; it is clinically used for the treatment of patients with the above symptoms such as acute hepatitis, upper respiratory tract infection, pneumonia, cerebral thrombosis, and cerebral hemorrhage.
The North American market for Qingkailing Injection is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Qingkailing Injection is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Qingkailing Injection include Yabao Pharmaceutical Group Co., Ltd., Jilin Province Ji'an Yisheng Pharmaceutical Co., Ltd., Shanxi Taihang Pharmaceutical Co., Ltd., Henan Province Shennong Pharmaceutical Co., Ltd., Guangdong Leiyunshang Pharmaceutical Co., Ltd., Shenwei Pharmaceutical Group Co., Ltd., Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd., etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Qingkailing Injection market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Qingkailing Injection. The Qingkailing Injection market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Qingkailing Injection market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Qingkailing Injection manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Yabao Pharmaceutical Group Co., Ltd.
Jilin Province Ji'an Yisheng Pharmaceutical Co., Ltd.
Shanxi Taihang Pharmaceutical Co., Ltd.
Henan Province Shennong Pharmaceutical Co., Ltd.
Guangdong Leiyunshang Pharmaceutical Co., Ltd.
Shenwei Pharmaceutical Group Co., Ltd.
Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd.
Segment by Type
2ml Each
10ml Each
by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Qingkailing Injection manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Qingkailing Injection sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Qingkailing Injection Market Overview
1.1 Product Definition
1.2 Qingkailing Injection by Type
1.2.1 Global Qingkailing Injection Market Value by Type: 2025 vs 2032
1.2.2 2ml Each
1.2.3 10ml Each
1.3 Qingkailing Injection by Application
1.3.1 Global Qingkailing Injection Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Qingkailing Injection Market Size Estimates and Forecasts
1.4.1 Global Qingkailing Injection Revenue 2021–2032
1.4.2 Global Qingkailing Injection Sales 2021–2032
1.4.3 Global Qingkailing Injection Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Qingkailing Injection Market Competition by Manufacturers
2.1 Global Qingkailing Injection Sales Market Share by Manufacturers (2021–2026)
2.2 Global Qingkailing Injection Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Qingkailing Injection Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Qingkailing Injection, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Qingkailing Injection, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Qingkailing Injection, Product Types and Applications
2.7 Global Key Manufacturers of Qingkailing Injection, Date of Entry into the Industry
2.8 Global Qingkailing Injection Market Competitive Situation and Trends
2.8.1 Global Qingkailing Injection Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Qingkailing Injection Players Market Share by Revenue
2.8.3 Global Qingkailing Injection Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Qingkailing Injection Market Scenario by Region
3.1 Global Qingkailing Injection Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Qingkailing Injection Sales by Region: 2021–2032
3.2.1 Global Qingkailing Injection Sales by Region: 2021–2026
3.2.2 Global Qingkailing Injection Sales by Region: 2027–2032
3.3 Global Qingkailing Injection Revenue by Region: 2021–2032
3.3.1 Global Qingkailing Injection Revenue by Region: 2021–2026
3.3.2 Global Qingkailing Injection Revenue by Region: 2027–2032
3.4 North America Qingkailing Injection Market Facts & Figures by Country
3.4.1 North America Qingkailing Injection Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Qingkailing Injection Sales by Country (2021–2032)
3.4.3 North America Qingkailing Injection Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Qingkailing Injection Market Facts & Figures by Country
3.5.1 Europe Qingkailing Injection Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Qingkailing Injection Sales by Country (2021–2032)
3.5.3 Europe Qingkailing Injection Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Qingkailing Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Qingkailing Injection Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Qingkailing Injection Sales by Region (2021–2032)
3.6.3 Asia Pacific Qingkailing Injection Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Qingkailing Injection Market Facts & Figures by Country
3.7.1 Latin America Qingkailing Injection Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Qingkailing Injection Sales by Country (2021–2032)
3.7.3 Latin America Qingkailing Injection Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Qingkailing Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Qingkailing Injection Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Qingkailing Injection Sales by Country (2021–2032)
3.8.3 Middle East and Africa Qingkailing Injection Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Qingkailing Injection Sales by Type (2021–2032)
4.1.1 Global Qingkailing Injection Sales by Type (2021–2026)
4.1.2 Global Qingkailing Injection Sales by Type (2027–2032)
4.1.3 Global Qingkailing Injection Sales Market Share by Type (2021–2032)
4.2 Global Qingkailing Injection Revenue by Type (2021–2032)
4.2.1 Global Qingkailing Injection Revenue by Type (2021–2026)
4.2.2 Global Qingkailing Injection Revenue by Type (2027–2032)
4.2.3 Global Qingkailing Injection Revenue Market Share by Type (2021–2032)
4.3 Global Qingkailing Injection Price by Type (2021–2032)
5 Segment by Application
5.1 Global Qingkailing Injection Sales by Application (2021–2032)
5.1.1 Global Qingkailing Injection Sales by Application (2021–2026)
5.1.2 Global Qingkailing Injection Sales by Application (2027–2032)
5.1.3 Global Qingkailing Injection Sales Market Share by Application (2021–2032)
5.2 Global Qingkailing Injection Revenue by Application (2021–2032)
5.2.1 Global Qingkailing Injection Revenue by Application (2021–2026)
5.2.2 Global Qingkailing Injection Revenue by Application (2027–2032)
5.2.3 Global Qingkailing Injection Revenue Market Share by Application (2021–2032)
5.3 Global Qingkailing Injection Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Yabao Pharmaceutical Group Co., Ltd.
6.1.1 Yabao Pharmaceutical Group Co., Ltd. Company Information
6.1.2 Yabao Pharmaceutical Group Co., Ltd. Description and Business Overview
6.1.3 Yabao Pharmaceutical Group Co., Ltd. Qingkailing Injection Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Yabao Pharmaceutical Group Co., Ltd. Qingkailing Injection Product Portfolio
6.1.5 Yabao Pharmaceutical Group Co., Ltd. Recent Developments/Updates
6.2 Jilin Province Ji'an Yisheng Pharmaceutical Co., Ltd.
6.2.1 Jilin Province Ji'an Yisheng Pharmaceutical Co., Ltd. Company Information
6.2.2 Jilin Province Ji'an Yisheng Pharmaceutical Co., Ltd. Description and Business Overview
6.2.3 Jilin Province Ji'an Yisheng Pharmaceutical Co., Ltd. Qingkailing Injection Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Jilin Province Ji'an Yisheng Pharmaceutical Co., Ltd. Qingkailing Injection Product Portfolio
6.2.5 Jilin Province Ji'an Yisheng Pharmaceutical Co., Ltd. Recent Developments/Updates
6.3 Shanxi Taihang Pharmaceutical Co., Ltd.
6.3.1 Shanxi Taihang Pharmaceutical Co., Ltd. Company Information
6.3.2 Shanxi Taihang Pharmaceutical Co., Ltd. Description and Business Overview
6.3.3 Shanxi Taihang Pharmaceutical Co., Ltd. Qingkailing Injection Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Shanxi Taihang Pharmaceutical Co., Ltd. Qingkailing Injection Product Portfolio
6.3.5 Shanxi Taihang Pharmaceutical Co., Ltd. Recent Developments/Updates
6.4 Henan Province Shennong Pharmaceutical Co., Ltd.
6.4.1 Henan Province Shennong Pharmaceutical Co., Ltd. Company Information
6.4.2 Henan Province Shennong Pharmaceutical Co., Ltd. Description and Business Overview
6.4.3 Henan Province Shennong Pharmaceutical Co., Ltd. Qingkailing Injection Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Henan Province Shennong Pharmaceutical Co., Ltd. Qingkailing Injection Product Portfolio
6.4.5 Henan Province Shennong Pharmaceutical Co., Ltd. Recent Developments/Updates
6.5 Guangdong Leiyunshang Pharmaceutical Co., Ltd.
6.5.1 Guangdong Leiyunshang Pharmaceutical Co., Ltd. Company Information
6.5.2 Guangdong Leiyunshang Pharmaceutical Co., Ltd. Description and Business Overview
6.5.3 Guangdong Leiyunshang Pharmaceutical Co., Ltd. Qingkailing Injection Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Guangdong Leiyunshang Pharmaceutical Co., Ltd. Qingkailing Injection Product Portfolio
6.5.5 Guangdong Leiyunshang Pharmaceutical Co., Ltd. Recent Developments/Updates
6.6 Shenwei Pharmaceutical Group Co., Ltd.
6.6.1 Shenwei Pharmaceutical Group Co., Ltd. Company Information
6.6.2 Shenwei Pharmaceutical Group Co., Ltd. Description and Business Overview
6.6.3 Shenwei Pharmaceutical Group Co., Ltd. Qingkailing Injection Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Shenwei Pharmaceutical Group Co., Ltd. Qingkailing Injection Product Portfolio
6.6.5 Shenwei Pharmaceutical Group Co., Ltd. Recent Developments/Updates
6.7 Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd.
6.7.1 Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd. Company Information
6.7.2 Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd. Description and Business Overview
6.7.3 Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd. Qingkailing Injection Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd. Qingkailing Injection Product Portfolio
6.7.5 Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Qingkailing Injection Industry Chain Analysis
7.2 Qingkailing Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Qingkailing Injection Production Mode & Process Analysis
7.4 Qingkailing Injection Sales and Marketing
7.4.1 Qingkailing Injection Sales Channels
7.4.2 Qingkailing Injection Distributors
7.5 Qingkailing Injection Customer Analysis
8 Qingkailing Injection Market Dynamics
8.1 Qingkailing Injection Industry Trends
8.2 Qingkailing Injection Market Drivers
8.3 Qingkailing Injection Market Challenges
8.4 Qingkailing Injection Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Qingkailing Injection Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Qingkailing Injection Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Qingkailing Injection Market Competitive Situation by Manufacturers in 2025
Table 4. Global Qingkailing Injection Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Qingkailing Injection Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Qingkailing Injection Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Qingkailing Injection Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Qingkailing Injection Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Qingkailing Injection, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Qingkailing Injection, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Qingkailing Injection, Product Types and Applications
Table 12. Global Key Manufacturers of Qingkailing Injection, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Qingkailing Injection Companies by Tier (Tier 1, Tier 2, Tier 3), based on Qingkailing Injection Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Qingkailing Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Qingkailing Injection Sales by Region (K Units), 2021–2026
Table 18. Global Qingkailing Injection Sales Market Share by Region (2021–2026)
Table 19. Global Qingkailing Injection Sales by Region (K Units), 2027–2032
Table 20. Global Qingkailing Injection Sales Market Share by Region (2027–2032)
Table 21. Global Qingkailing Injection Revenue by Region (US$ Million), 2021–2026
Table 22. Global Qingkailing Injection Revenue Market Share by Region (2021–2026)
Table 23. Global Qingkailing Injection Revenue by Region (US$ Million), 2027–2032
Table 24. Global Qingkailing Injection Revenue Market Share by Region (2027–2032)
Table 25. North America Qingkailing Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Qingkailing Injection Sales by Country (K Units), 2021–2026
Table 27. North America Qingkailing Injection Sales by Country (K Units), 2027–2032
Table 28. North America Qingkailing Injection Revenue by Country (US$ Million), 2021–2026
Table 29. North America Qingkailing Injection Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Qingkailing Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Qingkailing Injection Sales by Country (K Units), 2021–2026
Table 32. Europe Qingkailing Injection Sales by Country (K Units), 2027–2032
Table 33. Europe Qingkailing Injection Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Qingkailing Injection Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Qingkailing Injection Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Qingkailing Injection Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Qingkailing Injection Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Qingkailing Injection Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Qingkailing Injection Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Qingkailing Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Qingkailing Injection Sales by Country (K Units), 2021–2026
Table 42. Latin America Qingkailing Injection Sales by Country (K Units), 2027–2032
Table 43. Latin America Qingkailing Injection Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Qingkailing Injection Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Qingkailing Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Qingkailing Injection Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Qingkailing Injection Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Qingkailing Injection Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Qingkailing Injection Revenue by Country (US$ Million), 2027–2032
Table 50. Global Qingkailing Injection Sales (K Units) by Type (2021–2026)
Table 51. Global Qingkailing Injection Sales (K Units) by Type (2027–2032)
Table 52. Global Qingkailing Injection Sales Market Share by Type (2021–2026)
Table 53. Global Qingkailing Injection Sales Market Share by Type (2027–2032)
Table 54. Global Qingkailing Injection Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Qingkailing Injection Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Qingkailing Injection Revenue Market Share by Type (2021–2026)
Table 57. Global Qingkailing Injection Revenue Market Share by Type (2027–2032)
Table 58. Global Qingkailing Injection Price (US$/Unit) by Type (2021–2026)
Table 59. Global Qingkailing Injection Price (US$/Unit) by Type (2027–2032)
Table 60. Global Qingkailing Injection Sales (K Units) by Application (2021–2026)
Table 61. Global Qingkailing Injection Sales (K Units) by Application (2027–2032)
Table 62. Global Qingkailing Injection Sales Market Share by Application (2021–2026)
Table 63. Global Qingkailing Injection Sales Market Share by Application (2027–2032)
Table 64. Global Qingkailing Injection Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Qingkailing Injection Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Qingkailing Injection Revenue Market Share by Application (2021–2026)
Table 67. Global Qingkailing Injection Revenue Market Share by Application (2027–2032)
Table 68. Global Qingkailing Injection Price (US$/Unit) by Application (2021–2026)
Table 69. Global Qingkailing Injection Price (US$/Unit) by Application (2027–2032)
Table 70. Yabao Pharmaceutical Group Co., Ltd. Company Information
Table 71. Yabao Pharmaceutical Group Co., Ltd. Description and Business Overview
Table 72. Yabao Pharmaceutical Group Co., Ltd. Qingkailing Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Yabao Pharmaceutical Group Co., Ltd. Qingkailing Injection Product
Table 74. Yabao Pharmaceutical Group Co., Ltd. Recent Developments/Updates
Table 75. Jilin Province Ji'an Yisheng Pharmaceutical Co., Ltd. Company Information
Table 76. Jilin Province Ji'an Yisheng Pharmaceutical Co., Ltd. Description and Business Overview
Table 77. Jilin Province Ji'an Yisheng Pharmaceutical Co., Ltd. Qingkailing Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Jilin Province Ji'an Yisheng Pharmaceutical Co., Ltd. Qingkailing Injection Product
Table 79. Jilin Province Ji'an Yisheng Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 80. Shanxi Taihang Pharmaceutical Co., Ltd. Company Information
Table 81. Shanxi Taihang Pharmaceutical Co., Ltd. Description and Business Overview
Table 82. Shanxi Taihang Pharmaceutical Co., Ltd. Qingkailing Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Shanxi Taihang Pharmaceutical Co., Ltd. Qingkailing Injection Product
Table 84. Shanxi Taihang Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 85. Henan Province Shennong Pharmaceutical Co., Ltd. Company Information
Table 86. Henan Province Shennong Pharmaceutical Co., Ltd. Description and Business Overview
Table 87. Henan Province Shennong Pharmaceutical Co., Ltd. Qingkailing Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Henan Province Shennong Pharmaceutical Co., Ltd. Qingkailing Injection Product
Table 89. Henan Province Shennong Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 90. Guangdong Leiyunshang Pharmaceutical Co., Ltd. Company Information
Table 91. Guangdong Leiyunshang Pharmaceutical Co., Ltd. Description and Business Overview
Table 92. Guangdong Leiyunshang Pharmaceutical Co., Ltd. Qingkailing Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Guangdong Leiyunshang Pharmaceutical Co., Ltd. Qingkailing Injection Product
Table 94. Guangdong Leiyunshang Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 95. Shenwei Pharmaceutical Group Co., Ltd. Company Information
Table 96. Shenwei Pharmaceutical Group Co., Ltd. Description and Business Overview
Table 97. Shenwei Pharmaceutical Group Co., Ltd. Qingkailing Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Shenwei Pharmaceutical Group Co., Ltd. Qingkailing Injection Product
Table 99. Shenwei Pharmaceutical Group Co., Ltd. Recent Developments/Updates
Table 100. Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd. Company Information
Table 101. Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd. Description and Business Overview
Table 102. Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd. Qingkailing Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd. Qingkailing Injection Product
Table 104. Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Qingkailing Injection Distributors List
Table 108. Qingkailing Injection Customers List
Table 109. Qingkailing Injection Market Trends
Table 110. Qingkailing Injection Market Drivers
Table 111. Qingkailing Injection Market Challenges
Table 112. Qingkailing Injection Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
Table 116. Authors List of This Report
List of Figures
Figure 1. Product Picture of Qingkailing Injection
Figure 2. Global Qingkailing Injection Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Qingkailing Injection Market Share by Type: 2025 & 2032
Figure 4. 2ml Each Product Picture
Figure 5. 10ml Each Product Picture
Figure 6. Global Qingkailing Injection Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Qingkailing Injection Market Share by Application: 2025 & 2032
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Other
Figure 11. Global Qingkailing Injection Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Qingkailing Injection Market Size (US$ Million), 2021–2032
Figure 13. Global Qingkailing Injection Sales (K Units), 2021–2032
Figure 14. Global Qingkailing Injection Average Price (US$/Unit), 2021–2032
Figure 15. Qingkailing Injection Report Years Considered
Figure 16. Qingkailing Injection Sales Share by Manufacturers in 2025
Figure 17. Global Qingkailing Injection Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Qingkailing Injection Players: Market Share by Revenue in Qingkailing Injection in 2025
Figure 19. Qingkailing Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Qingkailing Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Qingkailing Injection Sales Market Share by Country (2021–2032)
Figure 22. North America Qingkailing Injection Revenue Market Share by Country (2021–2032)
Figure 23. United States Qingkailing Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Qingkailing Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Qingkailing Injection Sales Market Share by Country (2021–2032)
Figure 26. Europe Qingkailing Injection Revenue Market Share by Country (2021–2032)
Figure 27. Germany Qingkailing Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Qingkailing Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Qingkailing Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Qingkailing Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Qingkailing Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Qingkailing Injection Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Qingkailing Injection Revenue Market Share by Region (2021–2032)
Figure 34. China Qingkailing Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Qingkailing Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Qingkailing Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Qingkailing Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Qingkailing Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Qingkailing Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Qingkailing Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Qingkailing Injection Sales Market Share by Country (2021–2032)
Figure 42. Latin America Qingkailing Injection Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Qingkailing Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Qingkailing Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Qingkailing Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Qingkailing Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Qingkailing Injection Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Qingkailing Injection Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Qingkailing Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Qingkailing Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Qingkailing Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Qingkailing Injection by Type (2021–2032)
Figure 53. Global Revenue Market Share of Qingkailing Injection by Type (2021–2032)
Figure 54. Global Qingkailing Injection Price (US$/Unit) by Type (2021–2032)
Figure 55. Global Sales Market Share of Qingkailing Injection by Application (2021–2032)
Figure 56. Global Revenue Market Share of Qingkailing Injection by Application (2021–2032)
Figure 57. Global Qingkailing Injection Price (US$/Unit) by Application (2021–2032)
Figure 58. Qingkailing Injection Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
